Dec 01st 2006 - Edison Investment Research today published a report on Amphion Innovations (AMP.L, LSE:AMP, LON:AMP) entitled "New Investments". In summary, the report says:
Amphion Innovations has made a sigificant investment in Myconostica, a spin-out from the University of Manchester developing a technology for the rapid diagnosis of life-threatening fungal infections. Myconostica will be Amphionâ€™s seventh partner company, its fifth in life sciences, and its second to be based in the UK.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »